Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,582 | -42,771 | -31,793 | -24,122 | -15,094 |
| Depreciation Amortization | 292 | 192 | 148 | 150 | 142 |
| Other Working Capital | -1,726 | 3,476 | 1,684 | 199 | 671 |
| Other Operating Activity | -1,568 | 6,725 | 4,738 | 1,205 | 349 |
| Operating Cash Flow | $-47,583 | $-32,377 | $-25,222 | $-22,569 | $-13,933 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -104 | -864 | -226 | -141 | -62 |
| Investing Cash Flow | $-104 | $-864 | $-226 | $-141 | $-62 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 184 |
| Common Stock Issued | 61,411 | 22,940 | N/A | 1,249 | 60,362 |
| Other Financing Activity | 0 | 0 | 9,611 | 0 | 0 |
| Financing Cash Flow | $61,411 | $22,940 | $9,611 | $1,249 | $60,546 |
| Beginning Cash Position | 9,565 | 19,866 | 35,704 | 57,165 | 10,615 |
| End Cash Position | 23,289 | 9,565 | 19,866 | 35,704 | 57,165 |
| Net Cash Flow | $13,724 | $-10,301 | $-15,838 | $-21,461 | $46,551 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,583 | -32,377 | -25,222 | -22,569 | -13,933 |
| Capital Expenditure | -104 | -864 | -226 | -141 | -62 |
| Free Cash Flow | -47,687 | -33,241 | -25,448 | -22,710 | -13,995 |